Introduction
The ability of lectins to bind to specific saccharides has made them valuable experimental tools. They have been used to explore differential glycosylation in various tissues and species [1] [2] [3] and to detect differences in glycosylation pattern associated with disease and malignancy. [4] [5] [6] They have also been used to discriminate between different cell types in tissues. 3, 7, 8 In the human lung, several studies have reported the results of lectin binding to various cells that comprise the airway epithelium. [4] [5] [6] 9, 10 However, such previous studies have relied on the use of fixed tissue, and as a result, it has been difficult to distinguish between binding to the extracellular surface of the apical membrane or to sites deeper within the epithelium and at the basolateral surface. Moreover, the methods used for tissue fixation and preparation may significantly influence lectin binding. 11, 12 Thus, a goal of this study was to identify lectins that bind specifically to the apical surface of living human airway epithelia. We used an in vitro model in which the epithelia are cultured at the air-liquid interface and differentiated to resemble the epithelia in vivo. 13 The specific binding of lectins has also been explored for targeting and enhancing the delivery of therapeutic agents. Several studies have examined this approach for the development of gene transfer. For example, lectins were included in a complex containing plasmid to enhance gene transfer to carcinoma cells.
14 For pulmonary applications, lectins have been used to target gene transfer vectors to human lung cancer cells. 15 In addition, lectins complexed with plasmid and either polylysine or histone were used to enhance gene transfer to airway epithelial cells. 16 However, these studies relied on epithelial cell lines that do not show the same morphological or functional differentiation as airway epithelia in vivo. Thus, the identification of lectins that bind to the apical surface of living, differentiated human airway epithelia could be of value for the development of therapeutic agents delivered to the airway. In addition to binding, most therapeutic applications such as gene transfer require uptake of the agent into the cell. Therefore, we also asked if lectins that bind to the cell surface are taken up by endocytosis.
Results

Lectin binding to the apical surface of human airway epithelial cultures
Primary cultures of human airway epithelia were grown on permeable filter supports at the air-liquid interface. They were studied at least 2 weeks following seeding at which time they develop a differentiated phenotype. We tested binding of 32 commercially available lectins that were coupled to FITC. They were applied to the apical surface of living epithelia in which the tight junctions limit access to the basolateral membrane and to basal cells. During application, epithelia were maintained at 4°C to prevent internalization. We tested addition of both 1 and 10 g of lectin.
Fifteen of the 32 lectins bound to the apical surface (Table 1) . However, the pattern of binding of the different lectins varied. Eight lectins showed a diffuse binding that covered almost the entire apical surface. This diffuse binding pattern suggests that these lectins bound to several different types of airway epithelial cells. Five lectins showed less binding than those in the diffuse group, binding to some, but not all, of the cells in the epithelium. Two of the lectins bound to less than 10% of the cells, suggesting binding to a few specific cell types. Figure 1 shows examples of a lectin that bound diffusely to the apical surface, Con A, a lectin that bound to most of the cells, Jacalin, and a lectin that bound to the apical surface of only a few cells, PNA.
Of the lectins that bound, some in each group required application at 1 g/ml to show a significant fluorescence signal, whereas most required 10 g/ml (Table 1) . Seventeen lectins either showed no binding at 10 g/ml or dis- Gene Therapy played an inconsistent pattern of binding when tested on multiple samples of airway epithelia. These data indicate that different populations of cells express specific saccharide moieties at the apical surface of airway epithelia.
Effect of blood type on lectin binding
Blood type is known to affect the binding of some lectins. 1, 2 To determine whether blood type affects lectin binding to the apical surface of airway epithelia, we examined epithelia cultured from lungs of blood type A, B, AB and O individuals. At least two different donors from each blood type group were studied with two epithelial samples from each individual. Of the 15 lectins that bound to the apical surface, all showed a consistent binding pattern regardless of the blood type.
Cell specificity of lectin binding to human airway epithelia
We also examined for cell specificity of lectins on sections of human tracheal epithelium. One lectin from each of the three different patterns of binding was chosen for evaluation (diffuse, Con A; selective to diffuse, Jacalin; and selective, PNA) ( Table 1) . After paraffin was removed from the tracheal sections and they were rehydrated with sequential ethanol baths, sections were incubated with biotinylated lectins and visualized using DAB substrate augmented with nickel ion. In order to identify the different cell types, sections were counterstained with hematoxylin and either eosin or PAS (Figure 2) . In agreement with our data on differentiated cultures, Con A bound diffusely to the apical surface of trachea. Jacalin, which showed an intermediate pattern of binding to cultured airway epithelia, displayed specific binding to PASpositive cells. This result suggested that Jacalin binds to the apical surface of goblet and/or serous cells. PNA, which bound to only a few cells in the cultured airway epithelial model, bound to only a few cells on tracheal sections. However, unlike Jacalin, PNA seemed to bind to subpopulations of both ciliated and nonciliated cells. This result suggested that not all ciliated or nonciliated cells have the same pattern and/or abundance of apical membrane glycosylation.
Endocytosis of lectins bound to the apical surface
Use of lectins as a targeting moiety to deliver agents from the apical surface requires endocytosis into the epithelial cells. Therefore we asked whether lectins that bind to the apical membrane are endocytosed. We studied the three representative lectins used above: Con A, Jacalin and PNA. Because diffuse targeting of the apical surface might be advantageous for delivering agents into the epithelium, we examined three additional lectins that showed diffuse binding: WGA, ECL and SBA. Apical endocytosis was assessed using lectins attached to two different fluorophores. First, a rodamine-labeled lectin was applied to the apical surface at 4°C for 1 h. Unbound lectin was then removed, and the temperature was increased to 37°C for 1 or 4 h to allow endocytosis to occur. Then the epithelia were chilled to 4°C, and the same lectin coupled to FITC was applied to the apical surface. After the FITC-coupled lectin was removed the epithelia were examined with confocal microscopy. A control group for each lectin was maintained at 4°C to prevent endocytosis. Figure 3 shows an example of images for epithelia lab- eled with Con A. For the control epithelium maintained at 4°C throughout, both the red rodamine-conjugated Con A and the green FITC-conjugated Con A were limited to the apical surface. This gives a yellow appearance at the apical membrane. When epithelia were incubated at 37°C, the apical membrane appeared yellow due to the presence of lectin labeled with both flurophores. However, the red rodamine-conjugated Con A also appeared in a punctate pattern beneath the apical surface ( Figure  3 ). These data indicate that epithelia took up the lectin into cytoplasmic endosomes. Endocytosis of Con A occurred within 1 h at 37°C, while ECL, Jacalin, PNA, and SBA were internalized within 4 h. WGA had minimal endocytosis even after 4 h ( Table 2 ).
To test further the endocytosis of apically bound lectin, we examined the effect of nocodazole and cytochalasin D. Nocodazole destabilizes microfilaments and cytochalasin D depolymerizes microtubules. 17 Earlier work with epithelia has shown that these agents each partially inhibit endocytosis and the trafficking of endosomes and together inhibit most transcytosis and movement of endosomes.
17,18 Figure 4 shows Z-series images. At 37°C, the red rodamine-conjugated Con A appears beneath the yellow apical surface (top panel). Incubation at 4°C prevented endocytosis. Nocodozole at both 33 and 330 m (second set of panels, Figure 4 ) limited internalization, and only a small amount of red staining appeared, just beneath the apical membrane. Cytochalasin D (third set Lectins bound to the apical surface of human airway epithelia and were endocytosed into the cells at different rates.
Figure 4 Nocodazole and cytochalasin D inhibit endocytosis of Con A. Human airway cells were treated with nocodazole and cytochalasin D and assayed for endocytosis. Stacked XZ confocal images are shown. Images are based on experiments done at least four times (n = 2).
of panels, Figure 4 ) also showed a dose-dependent reduction of endocytosis. The combination of nocodazole and cytochalasin D (bottom panel) completely inhibited endocytosis.
Discussion
The results of this study show lectin binding specifically to the apical membrane of well-differentiated human airway epithelia. The methods we used have the advantage that binding was limited specifically to the extracellular surface of the apical membrane. This approach also allowed us to avoid the reported complications in lectin binding that can be introduced when tissue is fixed. 11, 12 It may also help minimize some of the inconsistencies noted in earlier studies. 4, 6 Finally, because we used living epithelia, the results may be of value for studies designed to target interventions to the epithelium from the apical surface.
Several previous studies have examined lectin binding to human airway epithelia [4] [5] [6] 9, 10 and in some cases the investigators examined lectin binding in the area of the apical membrane. 5, 9, 10 Our data correspond for the most part with previously published observations, although there were some significant differences. Combining our data with earlier work provides a better understanding of the lectin-binding patterns in human airway epithelia.
Some lectins can be used to identify basal cells. Dorscheid et al 9 found that the lectins EEL and PHA-L bound to basal cells, but they showed no binding to ciliated or goblet cells. Our findings that these lectins did not bind to the apical surface of differentiated airway epithelia are consistent with their data. Because we applied lectins to the apical surface, they would not have access to basal cells. Moreover, Dorscheid's finding that these lectins bound to two airway epithelial cell lines, 1HAEo-and 16HBE14o-, 9 are consistent with a basal cell phenotype for those cells.
Our finding that Jacalin bound to the apical membrane of some but not all epithelia and predominately to goblet cells is in agreement with previous work. 9 Thus this lectin may be useful in identifying cells with a goblet cell phenotype when it is applied to the apical surface.
We identified several lectins that bound diffusely to the apical membrane of nearly all epithelial cells. The results for ECL, LEL and WGA are in good agreement with other reports. 5, 9, 11 However consistent with earlier work, we did not identify lectins that bound exclusively to ciliated epithelial cells. The lack of binding of DSL, GSLII, LCA, SJA, STA and PHA-E in our study also corresponds with a previous report. 9 There were also some differences between our data and other reports. For example, we found PNA binding to the apical surface of only a few epithelial cells. Likewise, in sections of tracheal epithelium we also saw binding to only a few cells, and interestingly it appeared that it was only a few ciliated and a few goblet cells that stained. These data suggest heterogeneity in cells that share a common morphology. This result may in part explain the diversity in previous reports indicating binding to ciliated cells, 9 to goblet cells, 10, 11 or to none of the surface cells. 4, 5 Another example of a discrepancy is that two studies 5, 9 reported binding of UEA-1 to most surface cells, whereas two other studies 4,10 saw variable binding between samples. Our data for UEA-1 also showed variable binding between samples. Conflicting results have also been published for the binding of the lectin DBA. 4, 5, 10 The lack of apical binding in our study suggests that binding sites that may exist in the epithelium are not accessible from the apical surface. Interestingly, with two lectins, SBA and SNA, we observed diffuse apical stain-ing, whereas this was not the case in other reports. For SBA, previous studies reported no binding, 4 variable binding, 5, 10 or binding predominantly to goblet cell or serous cells. 2, 11 For SNA, one previous report suggested moderate binding to secretory cells. 9 It is possible that we observed binding because we did not fix or otherwise manipulate the epithelium before applying the lectin. In addition, our sensitivity to detect binding was likely greater because of the combination of our use of fluorescently tagged lectins and examination of the apical surface only, two factors that will improve the signal-tonoise ratio in detecting lectin binding.
Schulte et al 1 and Spicer et al 2 reported that lectin binding was altered in mucus, tracheal mucous cells, and submucosal glands in individuals with different ABO blood types. However, they noted that secretions from serous cells were not affected by different ABO blood types. Our study found that the 15 lectins that bound the apical surface were not affected by ABO blood type. Thus the material stored in mucous cells may have a different glycosylation pattern compared with apically expressed glycoproteins/lipids. It remains possible however, that other lectins will show selective apical binding depending on blood group type.
The results of this study may also be of value for investigators attempting to use lectins or related molecules to target the airway epithelium from the luminal surface. The identification of lectins that bind to the apical surface in living cells is an advantage for such studies. In addition, the finding that some lectins are rapidly internalized could be of value for several applications. One example is in the development of gene therapy. A current limitation in the development of gene therapy for diseases such as cystic fibrosis is that the binding and cellular uptake of many currently used vectors is very limited. 19 Several investigators have begun to explore the use of lectins to increase gene transfer to epithelia and lung cancer lines. [14] [15] [16] Our findings may be useful in developing new approaches to target the epithelium for gene transfer with both viral vectors and nonviral vector conjugates.
Materials and methods
Tissue specimen and culture Human tracheal sections and the airway epithelial cells were obtained from lungs removed for organ donation. The cells for culture were isolated from trachea and bronchi by enzyme digestion as previously described. [20] [21] [22] Freshly isolated cells were seeded at a density of 5 × 10 5 cells/cm 2 on to collagen-coated, 0.6-cm 2 area Millicell polycarbonate filters (Millipore, Bedford, MA, USA). The cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 and air. Twenty-four hours after plating, the mucosal medium was removed and the cells were allowed to grow at the air-liquid interface. [20] [21] [22] The culture medium consisted of a 1:1 mix of DMEM:Ham's F12, 5% Ultraser G (Biosepra, Cergy-Saint-Christophe, France), 100 U/ml penicillin, 100 g/ml streptomycin, 1% nonessential amino acids, and 0.12 U/ml insulin. Airway epithelia were allowed to reach confluence and develop a transepithelial electrical resistance, indicating the development of tight-junctions and an intact barrier. Epithelia were then differentiated by culturing for at least Gene Therapy 14 days after seeding and the presence of a ciliated surface was tested by scanning electron microscopy. 22 Lectin binding assay Binding of lectins on the apical surface of cultured human airway epithelia was performed by incubating cells with various FITC-conjugated lectins (Vector Laboratories, Burlingame, CA, USA). Briefly, the epithelia were chilled to 4°C and the apical surface was rinsed three times with PBS with 0.9 mm Ca 2+ and 0.9 mm Mg 2+ before the apical surface was incubated with 1 or 10 g/ml of lectin in PBS containing Ca 2+ and Mg
2+
. Cultures were incubated at 4°C for 1 h, rinsed three times, fixed with 4% paraformaldehyde in PBS, and mounted on glass slides using Vectashield with DAPI (Vector Laboratories). Binding of lectin to the apical membrane of epithelia was detected with fluorescence microscopy at 20× magnification.
Cell specificity assay
Cell specificity of lectin binding was also assayed using human tracheal sections. Briefly, trachea were fixed with 4% paraformaldehyde, embedded in paraffin, and cut into 4-m-thick sections. After paraffin was removed with xylene, the sections were rehydrated in sequential ethanol baths. Between incubations, the sections were rinsed with PBS. Endogenous peroxidases were quenched by 0.3% H 2 O 2 for 30 min and then the sections were incubated with 10 g/ml biotinylated lectins for 1 h at room temperature. Following 30-min incubation with Vectastain Elite ABC reagent (Vector Laboratories), 3, 3'-diaminobenzidine (DAB) augmented with nickel plus H 2 O 2 (Vector Laboratories) was applied for approximately 2 min. Sections were then counterstained with hematoxylin and either eosin or periodic acid-Schiff (PAS) using standard methods.
Endocytosis assay
Endocytosis of lectins was assayed using various rodamine-and FITC-conjugated lectins with laser scanning confocal microscopy (model MRC-1024 microscope; BioRad, Hercules, CA, USA). Briefly, the apical surface of normal airway epithelia was incubated with rodamine-conjugated lectin at 4°C for 1 h as stated above, rinsed three times, and incubated at 37°C for 1 or 4 h to allow endocytosis to occur. Then the epithelia were chilled to 4°C before the apical surface was labeled with FITC conjugated lectin for 1 h at 4°C. After rinsing three times, epithelia were fixed and mounted as stated above.
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